Nat Commun

Just two days of oatmeal may drive meaningful cholesterol drops in metabolic syndrome

March 10, 2026

This randomized controlled trial tested a two‑day high‑dose oat diet and a six‑week moderate‑dose regimen in adults with metabolic syndrome. Both interventions increased plasma ferulic acid while only the high‑dose diet increased dihydroferulic acid. These microbial phenolic metabolites are associated with improved lipid metabolism. The short‑term high‑dose diet lowered total and LDL cholesterol within 48 hours, suggesting rapid microbiome‑mediated effects that may counter obesity‑related dyslipidemia.

Clinical takeaway: For patients with metabolic syndrome, recommending higher‑dose, fiber‑rich oat intake—even over short periods—may meaningfully lower LDL cholesterol by enhancing beneficial gut‑derived phenolic metabolites.

Source:

Klümpen L, et al. (2026, January 14). Nat Commun. Cholesterol-lowering effects of oats induced by microbially produced phenolic metabolites in metabolic syndrome: a randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/41535271/